IDEAYA Biosciences, Inc. IDYA
26.18 USD -0.31 (-1.18%)
As ofNov 19, 2026, 1:57 PM EST
26.05 Day range 27.44
26.02 52-week range 42.68
- YTD
- -24.28%
- 1 year
- -20.99%
IDYA revenue history
Revenue is income from the company’s ordinary business activities.
218,710,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 218,710,000 | 211,710,000 | 3024.43% |
| FY 2024 | 2024-12-31 | 7,000,000 | -16,385,000 | -70.07% |
| FY 2023 | 2023-12-31 | 23,385,000 | -27,546,000 | -54.08% |
| FY 2022 | 2022-12-31 | 50,931,000 | 22,990,000 | 82.28% |
| FY 2021 | 2021-12-31 | 27,941,000 | 8,403,000 | 43.01% |
| FY 2020 | 2020-12-31 | 19,538,000 | 19,538,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-05T07:00:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
